Developmental outcomes after soybean oil vs mixed-oil intravenous lipid emulsions in neonates: A secondary analysis of a clinical trial.

Area of Science:

• Neonatal care
• Neurodevelopmental pediatrics
• Parenteral nutrition

Background:

• Fatty acids are crucial for brain development, and lipid injectable emulsions (LIEs) affect a neonate's fatty acid profile.
• Infants with intestinal failure rely on parenteral nutrition (PN), making LIE choice critical during rapid brain development.

Purpose of the Study:

• To compare 3-year neurodevelopmental outcomes in infants receiving soy oil versus mixed-oil lipid emulsions.
• To assess the impact of different LIEs on infant development following PN-dependent intestinal failure.

Main Methods:

• Randomized trial assigning 24 infants to soy oil or mixed-oil LIEs.
• 3-year follow-up using Ages & Stages Questionnaires-3 (ASQ-3) for neurodevelopmental screening.
• Previous report focused on intestinal failure-associated liver disease incidence.

Main Results:

• No significant differences in ASQ-3 scores or developmental delay rates across five domains between groups.
• No correlation found between peak direct bilirubin, gestational age, or lipid exposure duration and developmental outcomes.
• Patient parameters at birth and screening were comparable between the soy oil and mixed-oil LIE groups.

Conclusions:

• Soy oil and mixed-oil LIEs did not show differential effects on neurodevelopment at 3 years in this pilot study.
• The study's secondary outcome nature necessitates larger, powered trials to confirm developmental findings.
• Further research is warranted to fully understand the long-term neurodevelopmental impact of different LIEs in neonates.